{
    "label": "Age of patient?",
    "node_type": "fieldset",
    "children": [
        {
            "label": "For patients 17 years or older",
            "outcome": "Authorization for Wegovy™ (semaglutide), may be approved when all of the criteria are met",
            "node_type": "radio",
            "node_value": false,
            "children": [
                {
                    "label": "Is this request for initiation or continuation of therapy with Wegovy™ (semaglutide)?",
                    "node_type": "fieldset",
                    "children": [
                        {
                            "label": "Start of therapy",
                            "outcome": "Authorization for Wegovy™ (semaglutide), may be approved when all of the criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "The patient is 17 years of age or older",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "The patient has either:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Documented diagnosis of obesity, confirmed by a body mass index (BMI) greater than or equal to 30 kg/m^2",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "A documented body mass index (BMI) greater than or equal to 25 kg/m^2 if the patient is of South Asian, Southeast Asian, or East Asian descent",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Meets body mass index (BMI) and comorbidity requirements:",
                                            "all_required": true,
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "children": [
                                                {
                                                    "label": "A documented body mass index (BMI) greater than or equal to 27 kg/m^2",
                                                    "node_type": "checkbox",
                                                    "node_value": false
                                                },
                                                {
                                                    "label": "Document all the weight-related comorbid conditions the patient has (at least one required):",
                                                    "node_type": "checkbox",
                                                    "node_value": false,
                                                    "children": [
                                                        {
                                                            "label": "Established cardiovascular disease or stroke",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Hypertension",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Type 2 diabetes (DM)",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Chronic kidney disease (CKD)",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Congenital heart disease (CHD)",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Obstructive sleep apnea",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Polycystic ovarian syndrome",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Dyslipidemia",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Non-alcoholic fatty liver disease",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Idiopathic intracranial hypertension",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Osteoarthritis in weight-bearing joints",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        }
                                                    ]
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "label": "Document that the patient has been on a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications for a minimum of 6 months prior to initiating therapy with Wegovy",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Document the patient did not achieve a weight loss of 1 pound or more per week while on the weight loss regimen prior to initiating therapy with Wegovy",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Document the patient is currently on and will continue a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "The patient does NOT have any FDA labeled contraindications to Wegovy:",
                                    "all_required": true,
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Document that the patient does NOT have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 or have a history of pancreatitis",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Document that the patient does NOT have a known hypersensitivity to semaglutide or any of the ingredients in Wegovy",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                },
                                {
                                    "label": "Document the patient will NOT be using the requested agent in combination with another targeted weight loss agent for the requested indication",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "One of the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Document the patient has not tried a targeted weight loss agent in the past 12 months",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Document the patient has tried a targeted weight loss agent for a previous course of therapy in the past 12 months AND the prescriber anticipates success with repeating therapy",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                },
                                {
                                    "label": "Document the patient will NOT be using Wegovy in combination with another GLP-1 receptor agonist agent",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "One of the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "The patient is newly starting therapy",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Document the patient is currently being treated and has received less than 52 weeks (1 year) of therapy",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Document the patient has achieved and maintained a weight loss of greater than or equal to 5% from baseline (prior to initiation of Wegovy)",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "label": "Continuation of therapy",
                            "outcome": "Authorization for Wegovy™ (semaglutide), may be approved when all of the criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "The patient has been previously approved for Wegovy through the plan's Prior Authorization process",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Document the patient is currently on and will continue to be on a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Document the patient does NOT have any FDA labeled contraindications to Wegovy",
                                    "all_required": true,
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "The patient does NOT have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 or have a history of pancreatitis",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },

                                        {
                                            "label": "The patient does NOT have a known hypersensitivity to semaglutide or any of the ingredients in Wegovy.",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                },
                                {
                                    "label": "The requested dose is 1.7 mg or 2.4 mg",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Document the patient will NOT be using Wegovy in combination with another GLP-1 receptor agonist agent",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "The patient meets one of the following requirements:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Document the patient has achieved and maintained a weight loss greater than or equal to 5% from baseline (prior to initiation of Wegovy)",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "The patient has received less than 52 weeks of therapy on the 2.4 mg dose",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                },
                                {
                                    "label": "Document the patient will NOT be using Wegovy in combination with another targeted weight loss agent for the requested indication",
                                    "node_type": "checkbox",
                                    "node_value": false
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "label": "For patients aged 12 to 16 years",
            "outcome": "Authorization for Wegovy™ (semaglutide), may be approved when all of the criteria are met",
            "node_type": "radio",
            "node_value": false,
            "children": [
                {
                    "label": "Is this request for initiation or continuation of therapy with Wegovy™ (semaglutide)?",
                    "node_type": "fieldset",
                    "children": [
                        {
                            "label": "Start of therapy",
                            "outcome": "Authorization for Wegovy™ (semaglutide), may be approved when all of the criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "The patient is 12 to 16 years of age",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "One of the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Document the patient has a diagnosis of obesity, confirmed by a body mass index (BMI) greater than or equal to 95th percentile for age and gender",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Document the patient has a diagnosis of obesity, confirmed by a body mass index (BMI) greater than or equal to 30 kg/m^2",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Meets body mass index (BMI) and comorbidity requirements:",
                                            "all_required": true,
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "children": [

                                                {
                                                    "label": "The patient has a documented body mass index (BMI) greater than or equal to 85th percentile for age and gender (>27 kg/m^2)",
                                                    "node_type": "checkbox",
                                                    "node_value": false
                                                },
                                                {
                                                    "label": "Document all the weight-related comorbid conditions the patient has (at least one required):",
                                                    "node_type": "checkbox",
                                                    "node_value": false,
                                                    "children": [
                                                        {
                                                            "label": "Established cardiovascular disease or stroke",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Hypertension",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Type 2 diabetes (DM)",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Chronic kidney disease (CKD)",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Congenital heart disease (CHD)",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Obstructive sleep apnea",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Polycystic ovarian syndrome",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Dyslipidemia",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Non-alcoholic fatty liver disease",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Idiopathic intracranial hypertension",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Osteoarthritis in weight-bearing joints",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        }
                                                    ]
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "label": "Document the patient has been on a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications for a minimum of 6 months prior to initiating therapy with Wegovy",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Document the patient did not achieve a weight loss of 1 pound or more per week while on the weight loss regimen prior to initiating therapy with Wegovy",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Document the patient is currently on and will continue a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                
                                {
                                    "label": "The patient does NOT have any FDA labeled contraindications to Wegovy:",
                                    "all_required": true,
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "The patient does NOT have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 or have a history of pancreatitis",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "The patient does NOT have a known hypersensitivity to semaglutide or any of the ingredients in Wegovy",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                },
                                {
                                    "label": "One of the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Document the patient has not tried a targeted weight loss agent in the past 12 months",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Document the patient has tried a targeted weight loss agent for a previous course of therapy in the past 12 months AND the prescriber anticipates success with repeating therapy",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                },
                                {
                                    "label": "Document the patient will NOT be using Wegovy in combination with another GLP-1 receptor agonist agent",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "One of the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "The patient is newly starting therapy",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Document the patient is currently being treated and has received less than 52 weeks (1 year) of therapy",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Document the patient has achieved and maintained a reduction in BMI of at least 5% from baseline (prior to initiation of the requested agent)",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "label": "Continuation of therapy",
                            "outcome": "Authorization for Wegovy™ (semaglutide), may be approved when all of the criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "The patient has been previously approved for Wegovy through the plan's Prior Authorization process",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Document the patient is currently on and will continue to be on a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "The patient does NOT have any FDA labeled contraindications to Wegovy",
                                    "all_required": true,
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Document the patient does NOT have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 or have a history of pancreatitis",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },

                                        {
                                            "label": "Document the patient does NOT have a known hypersensitivity to semaglutide or any of the ingredients in Wegovy.",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                },
                                {
                                    "label": "The requested dose is 1.7 mg or 2.4 mg",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "The patient meets one of the following requirements:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Document the patient has received less than 52 weeks of therapy on the maximum-tolerated dose (2.4 mg or 1.7 mg)",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Document the patient has achieved and maintained a reduction in BMI of at least 5% from baseline (prior to initiation of the requested agent)",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                },
                                {
                                    "label": "The patient is 12 to less than 18 years of age AND the current BMI is greater than 85th percentile for age and gender",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Document the patient will NOT be using Wegovy in combination with another targeted weight loss agent for the requested indication",
                                    "node_type": "checkbox",
                                    "node_value": false
                                }
                            ]
                        }
                    ]
                }
            ]
        }
    ]
}